[Dynamics of the distribution of rifocin in patients with chronic tonsillitis at different methods of administration].
D000293:Adolescent; D000328:Adult; D000336:Aerosols; D000667:Ampicillin / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000302:isolation & purification*; D002648:Child; D002908:Chronic Disease; D003864:Depression, Chemical; D004917:Erythromycin / Q000494:pharmacology; D015643:Erythromycin Ethylsuccinate / Q000494:pharmacology; D006801:Humans; D007273:Injections, Intramuscular; D007478:Iontophoresis; D008690:Methacycline / Q000494:pharmacology; D008712:Methicillin / Q000494:pharmacology; D008875:Middle Aged; D009355:Neomycin / Q000494:pharmacology; D009827:Oleandomycin / Q000494:pharmacology; D010068:Oxacillin / Q000494:pharmacology; D014066:Palatine Tonsil / Q000032:analysis / Q000382:microbiology; D010403:Penicillin Resistance; D012293:Rifampin / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000652:urine; D012463:Saliva / Q000032:analysis; D013210:Staphylococcus / Q000187:drug effects*; D013291:Streptococcus / Q000187:drug effects*; D013752:Tetracycline / Q000494:pharmacology; D013997:Time Factors; D014069:Tonsillitis / Q000097:blood / Q000378:metabolism* / Q000382:microbiology / Q000652:urine
D000336:Aerosols; D000900:Anti-Bacterial Agents; D015643:Erythromycin Ethylsuccinate; D004917:Erythromycin; D000667:Ampicillin; D013752:Tetracycline; D009355:Neomycin; D008690:Methacycline; D009827:Oleandomycin; D008712:Methicillin; D010068:Oxacillin; D012293:Rifampin
Dinamika raspredeleniia rifotsina v organizme bol'nykh khronicheskim tonzillitom pri razlichnykh metodakh vvedeniia.